drugset / Trial / NCT01720030

Levosimendan in Acute Kidney Injury Study

NCT01720030

RandomizedParallel-groupQuadruple-blindTreatment

Summary

We hypothesise that levosimendan will have a positive influence on renal function during acute kidney injury in adult intensive care patients.

Timeline

Start
2016-09
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levosimendan Other / unclassified 0.2 ug/kg

Indications